Drug Database
Back to search

United States· US:33332-125_e60b3b79-2ae2-43b1-9192-9a5ed7c70d5e

Afluria

A medicinal product containing influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (propiolactone inactivated); influenza a virus a/croatia/10136rv/2023 x-425a (h3n2) antigen (propiolactone inactivated); influenza b virus b/austria/1359417/2021 bvr-26 antigen (propiolactone inactivated), registered in United States by Seqirus PTY LTD..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAfluriaATC—REGISTER NO.US:33332-125_e60b3b79…PACKS LISTED2CHECKEDJuly 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (propiolactone inactivated); influenza a virus a/croatia/10136rv/2023 x-425a (h3n2) antigen (propiolactone inactivated); influenza b virus b/austria/1359417/2021 bvr-26 antigen (propiolactone inactivated)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED)
Manufacturer
Seqirus PTY LTD.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
July 26, 2026

Packs & prices · 2

  • ndc11
    33332-125-10
  • ndc11
    3333212510
    1 VIAL, MULTI-DOSE in 1 CARTON (33332-125-10) / 5 mL in 1 VIAL, MULTI-DOSE (33332-125-11)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b586b1a4-d6bd-4007-8c4e-50ac4282243c
GET /v1/drugs/b586b1a4-d6bd-4007-8c4e-50ac4282243c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAMUSCULAR",
  "source": "ndc",
  "strength": "15; 15; 15",
  "substance": "INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED)",
  "productndc": "33332-125",
  "dosage_form": "INJECTION, SUSPENSION",
  "dea_schedule": null,
  "strength_unit": "ug/.5mL; ug/.5mL; ug/.5mL",
  "application_number": "BLA125254",
  "marketing_category": "BLA"
}
API referenceMCP serverPlans

See everything about influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (propiolactone inactivated); influenza a virus a/croatia/10136rv/2023 x-425a (h3n2) antigen (propiolactone inactivated); influenza b virus b/austria/1359417/2021 bvr-26 antigen (propiolactone inactivated).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console